Why The Technology Doctor

Not Another Consultant

What makes this practice different from a generic advisory — or a vendor with something to sell.

Diagnosis First

No treatment without diagnosis, no prescription without root cause. Every symptom is traced to the specific diseases behind it.

Every engagement starts with the Growth Blocker MRI Dx™ — nine dimensions, severity-scored.

Independent & Vendor-Neutral

No partnerships to push, nothing to resell. The recommendation is whatever is right for the business — even if it's "do nothing".

No cloud, tool, agency or hiring-vendor commissions — ever.

A Builder, Not Just an Advisor

20+ years architecting 15+ platforms and 100+ production AI agents — advice grounded in having actually built and re-architected systems at scale.

EasyGov · Bank 3.0 · GBP One Platform — built first-hand, not from a slide.

Proprietary Diagnostic IP

9 CEO symptoms, 78 named technology diseases, and the Growth Blocker MRI Dx™, Growth Accelerator Rx™ and Growth Transformation Tx™ frameworks.

9 symptoms · 78 diseases · 451 root causes — a structured method, not opinion-led consulting.

The Offering Ladder

Six Ways CEOs Engage

Pick the entry point that fits where you are. Each one connects to the next — most CEOs start with a call or a diagnosis and step up from there.

01 Entry Point

Advisory / Spot Consultancy Call

A focused senior advisory engagement for CEOs, founders, CTOs, COOs, investors or boards who need independent technology advice, a second opinion, quick triage, or validation before a major decision.

Technology roadmap or architecture review
Production-issue or platform triage
Second opinion before replatforming, cloud, AI or hiring decisions
Leadership alignment before committing budget

Best for: a fast second opinion, triage, or validating a big decision before you commit.

Output: a clear read on the likely root cause and the right next step.

Book This Call

02 Diagnostic & Prescription

Growth Blocker MRI Dx™ Diagnostic & Prescription

A CEO-level diagnosis of the technology, product, architecture, data, AI, cost, customer experience, quality and execution blockers limiting business growth — ending in a diagnosis plus a 30/60/90-day prescription.

Nine diagnostic dimensions, severity-classified
Symptom-to-root-cause mapping (78 diseases)
AI & data readiness assessment
Stop / Start / Continue / Delay decisions
Board-readable architecture & investment direction

Best for: when growth is stalling and you can't see why — the standard entry point.

Output: a board-ready diagnosis and a prioritised recovery prescription.

Start the Diagnostic

03 Ongoing Leadership

Fractional CTO / CTPO Advisory

Ongoing executive technology & product leadership for companies that need senior direction but don't yet have the right full-time capacity or maturity to execute the prescription alone.

Advisory Retainer — senior external validation
Fractional CTO / CTPO — embedded leadership cadence
Transformation Doctor — recovery governance
Architecture, AI, cost, quality & platform review

Best for: companies that need senior tech leadership without a full-time hire yet.

Output: a senior leadership cadence that keeps recovery on track.

Discuss Engagement

04 Treatment Execution

Transformation Program

A technology-led business transformation program that executes the prescribed recovery roadmap. Evidence-driven, not fashion-driven — and AI-first by default.

Technology Operating Model Transformation
Platform Modernization & Re-architecture
AI-First Readiness & Execution Program
Quality, Observability & FinOps Transformation
E-commerce Growth Technology Program

Best for: executing a prescribed recovery across platform, quality, cost and AI.

Output: measurable movement on growth, cost, quality and speed.

Scope a Program

05 Board & Investor

Board / Investor Technology Advisory

Independent technology clarity for PE firms, VC funds, boards, acquirers and portfolio companies — from pre-investment diligence through post-investment value creation.

Pre-investment technology & AI due diligence
Post-investment value creation roadmap
Portfolio technology review & CTO hiring support
Transformation oversight & risk visibility

Best for: PE/VC and boards needing independent diligence or post-deal value creation.

Output: independent technology risk and value visibility.

Engage the Doctor

06 AI Acceleration

AI Strategy & Implementation

Practical AI acceleration — not AI theatre. From use-case prioritization and readiness to agentic AI systems, automation implementation, governance and ROI measurement.

AI Strategy & Use-Case Prioritization
AI Readiness Assessment
Agentic AI Systems Design & Build
AI Governance, Risk & ROI Measurement

Best for: turning AI from stalled pilots into governed, ROI-positive systems.

Output: AI that produces business value — with governance.

Build the AI Plan

How to Choose

Which Engagement Fits You

Not sure where to start? Match your situation to the right entry point.

You need a fast second opinion or triage → Advisory / Spot Call

Growth is stalling and you can't see why → Growth Blocker MRI Dx™

You need senior leadership to steer the recovery → Fractional CTO / CTPO

You have the diagnosis — now you need execution → Transformation Program

You're investing in or governing a company → Board / Investor Advisory

You want AI to actually pay off → AI Strategy & Implementation

Proof

Advice Backed by Platforms Actually Built

Across Jio, Wayfair, Amdocs, Group Bayport and more — diagnosed, architected and re-architected at scale.

15+

Platforms Architected

1.3B+

Citizens Served

99.99%

Platform Uptime

100+

AI Agents in Production

See the Case Studies

Who This Practice Helps

Built For Senior Decision-Makers

CEOs & Founders

Who can see business pain but cannot clearly see the technology disease behind it.

Boards & Investors

Who need independent technology risk, value visibility, due diligence or portfolio review.

CTOs & CPOs

Who want external validation, strategic challenge or independent diagnosis from a peer.

COOs & Operations

Dealing with operational friction created by systems, workflows and platform limitations.

Growth-Stage Companies

Where business ambition has outgrown the current technology operating model.

PE & VC Funds

Evaluating technology maturity, scalability risk and post-investment value creation.

Questions

Before You Reach Out

How does an engagement start?

Always with a conversation. The Advisory Call — or the Growth Blocker MRI Dx™ — establishes the likely root cause before any larger commitment.

Are you independent?

Yes — vendor-neutral. No partnerships to push and nothing to resell. The recommendation is whatever is right for the business.

Do you work remotely or on-site?

Both. Diagnosis and advisory run mostly remote; transformation and fractional engagements blend a remote cadence with on-site time as needed.

Who owns the deliverables?

You do. Diagnoses, roadmaps and any code built for your engagement are yours, under NDA.

What if no engagement is the right answer?

Then that's what you'll hear. If the diagnosis says "nothing further needed", that's the recommendation — no manufactured scope.

Who is this for?

Growth-stage and enterprise companies — and their boards and investors — where technology has become a blocker to growth.

Not Sure Which Engagement Fits?

Start with the Advisory Call. We'll know within one focused conversation whether the right next step is the Growth Blocker MRI Dx™, fractional leadership, a transformation program, an AI plan — or nothing further.

Book the Advisory Call See the Method

Six Ways CEOs Engage Every One Begins with Diagnosis